ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 72 filers reported holding ALBIREO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $935,043 | -83.6% | 43,269 | -85.3% | 0.00% | -100.0% |
| Q3 2022 | $5,694,000 | +79.1% | 294,071 | +83.8% | 0.00% | 0.0% |
| Q2 2022 | $3,179,000 | -16.6% | 160,021 | +25.2% | 0.00% | 0.0% |
| Q1 2022 | $3,812,000 | +97.1% | 127,806 | +53.9% | 0.00% | – |
| Q4 2021 | $1,934,000 | -19.8% | 83,043 | +7.5% | 0.00% | – |
| Q3 2021 | $2,412,000 | +32.8% | 77,271 | +49.6% | 0.00% | – |
| Q2 2021 | $1,816,000 | +75.3% | 51,635 | +75.6% | 0.00% | – |
| Q1 2021 | $1,036,000 | -66.5% | 29,400 | -64.3% | 0.00% | – |
| Q4 2020 | $3,090,000 | -67.4% | 82,372 | -71.0% | 0.00% | -100.0% |
| Q3 2020 | $9,475,000 | +1249.7% | 283,921 | +971.6% | 0.00% | – |
| Q2 2020 | $702,000 | +296.6% | 26,495 | +145.6% | 0.00% | – |
| Q1 2020 | $177,000 | – | 10,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |